SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524689

INE904D01019

-300.6045095

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PDPL

10.11

EPS(TTM)

Face Value()

Div & Yield %

Back

kenvi jewels ltd

Trident consolidated net profit rises 9.30% in the September 2025 quarter

Nov 14,2025

Net profit of Trident rose 9.30% to Rs 90.93 crore in the quarter ended September 2025 as against Rs 83.19 crore during the previous quarter ended September 2024. Sales rose 4.33% to Rs 1787.17 crore in the quarter ended September 2025 as against Rs 1712.94 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1787.17	1712.94	4
OPM %	11.99	13.21	-
PBDT	206.84	191.26	8
PBT	123.96	99.07	25
NP	90.93	83.19	9

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)